Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1318 |
| Name of the vaccine | PXVX0200 |
| Microbe | Bacteria |
| Disease name | Cholera |
| Name of bacteria | Vibrio cholerae |
| Type of vaccine | Live attenuated |
| Nucleic acid content | DNA |
| Age | 18 to 45 years |
| Description of the vaccine | Live Oral cholera vaccine, CVD 103-HgR. |
| Name of the manufacturer | Emergent BioSolutions |
| Name of the manufacturing country | United States |
| Year of manufacture | 2014 |
| Clinical Phase status | Clinical - Phase 3 |
| Bacterial strain | Gram negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | Liquid suspension after reconstitution with buffer |
| Dosage | Single dose. |
| Mechanism of action | NA |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | 21498389 |
| Clinical trial number | NCT01895855 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |